282 related articles for article (PubMed ID: 36936715)
1. Epidemiology and mortality outcome of carbapenem- and colistin-resistant
Balkhair A; Saadi KA; Adawi BA
IJID Reg; 2023 Jun; 7():1-5. PubMed ID: 36936715
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
[TBL] [Abstract][Full Text] [Related]
3. Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
Garza-Ramos U; Silva-Sánchez J; López-Jácome LE; Hernández-Durán M; Colín-Castro CA; Sánchez-Pérez A; Rodríguez-Santiago J; Morfín-Otero R; Rodriguez-Noriega E; Velázquez-Acosta MD; Vázquez-Larios MDR; Feliciano-Guzmán JM; Rojas-Larios F; Ponce-De-Leon A; Lozano-Garcia M; Choy-Chang EV; López-Gutiérrez E; Molina-Jaimes A; Gil-Veloz M; Corte-Rojas RE; López-Ovilla I; Ramirez-Mis JL; Rodríguez-Balderas DE; Molina-Chavarria A; Padilla-Ibarra C; Quevedo-Ramos MA; Mireles-Dávalos CD; Rodríguez-Medina N; Rubio-Mendoza D; Córdova-Fletes C; Cruz-López F; Becerra-Montejano DA; Mercado-Longoria R; Martínez-Villarreal RT; Barlandas-Rendón NRE; Mena-Ramírez JP; Couoh-May CA; Alcaraz-Espejel M; Adame-Alvarez C; Hernández-Vicente L; Garza-González E
Microb Drug Resist; 2023 Jun; 29(6):239-248. PubMed ID: 36595348
[TBL] [Abstract][Full Text] [Related]
4. Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.
Alcántar-Curiel MD; Huerta-Cedeño M; Jarillo-Quijada MD; Gayosso-Vázquez C; Fernández-Vázquez JL; Hernández-Medel ML; Zavala-Pineda M; Morales-Gil MÁ; Hernández-Guzmán VA; Bolaños-Hernández MI; Giono-Cerezo S; Santos-Preciado JI
PeerJ; 2023; 11():e15007. PubMed ID: 37013147
[TBL] [Abstract][Full Text] [Related]
5. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Zhang X; Gu B; Mei Y; Wen Y; Xia W
J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
[TBL] [Abstract][Full Text] [Related]
6. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
8. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India.
Manohar P; Shanthini T; Ayyanar R; Bozdogan B; Wilson A; Tamhankar AJ; Nachimuthu R; Lopes BS
J Med Microbiol; 2017 Jul; 66(7):874-883. PubMed ID: 28671537
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Mohanty S; Maurya V; Gaind R; Deb M
J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
[TBL] [Abstract][Full Text] [Related]
10. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
[TBL] [Abstract][Full Text] [Related]
11. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009).
Kateete DP; Nakanjako R; Namugenyi J; Erume J; Joloba ML; Najjuka CF
Springerplus; 2016; 5(1):1308. PubMed ID: 27547682
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia.
D'Onofrio V; Conzemius R; Varda-Brkić D; Bogdan M; Grisold A; Gyssens IC; Bedenić B; Barišić I
Infect Genet Evol; 2020 Jul; 81():104263. PubMed ID: 32105865
[TBL] [Abstract][Full Text] [Related]
15. bla
Aruhomukama D; Najjuka CF; Kajumbula H; Okee M; Mboowa G; Sserwadda I; Mayanja R; Joloba ML; Kateete DP
BMC Infect Dis; 2019 Oct; 19(1):853. PubMed ID: 31619192
[TBL] [Abstract][Full Text] [Related]
16. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
Laishram S; Anandan S; Devi BY; Elakkiya M; Priyanka B; Bhuvaneshwari T; Peter JV; Subramani K; Balaji V
J Chemother; 2016 Aug; 28(4):297-303. PubMed ID: 27461479
[TBL] [Abstract][Full Text] [Related]
17. Global Prevalence of Colistin Resistance in
Uzairue LI; Rabaan AA; Adewumi FA; Okolie OJ; Folorunso JB; Bakhrebah MA; Garout M; Alfouzan WA; Halwani MA; Alamri AA; Halawani SA; Alshahrani FS; Hasan A; Mutair AA; Alhumaid S; Etafo J; Utip I; Odoh IM; Uwaezuoke NS
Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297149
[TBL] [Abstract][Full Text] [Related]
18. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
[TBL] [Abstract][Full Text] [Related]
19. Utilization of Vector Autoregressive and Linear Transfer Models to Follow Up the Antibiotic Resistance Spiral in Gram-negative Bacteria From Cephalosporin Consumption to Colistin Resistance.
Tóth H; Fésűs A; Kungler-Gorácz O; Balázs B; Majoros L; Szarka K; Kardos G
Clin Infect Dis; 2019 Sep; 69(8):1410-1421. PubMed ID: 30561543
[TBL] [Abstract][Full Text] [Related]
20. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.
Musila L; Kyany'a C; Maybank R; Stam J; Oundo V; Sang W
PLoS One; 2021; 16(2):e0246937. PubMed ID: 33617559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
